| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |